Replies to post #14532 on RespireRx Pharmaceuticals Inc (RSPI)

[RBlatch45]

Roger Stoll advised last night that he was told by the FDA Project Manager that the long awaited FDA letter for the CX717 IND rejection, should arrive "shortly".

Pathetic performance by yet another government agency... six months to get a letter out.


Cordially,
RBlatch